## Correct Answer: A. Rebound hypertension Clonidine is a central α₂-adrenergic agonist that suppresses sympathetic outflow and lowers blood pressure. During chronic use, the body adapts by upregulating α₂-adrenergic receptors and increasing sympathetic tone as a compensatory mechanism. When clonidine is abruptly discontinued, this compensatory sympathetic hyperactivity is unopposed, causing a sudden surge in catecholamine release and a marked increase in blood pressure—a phenomenon called **rebound hypertension**. This acute elevation in blood pressure manifests clinically as severe headache, palpitations, and anxiety, typically occurring within 12–48 hours of drug withdrawal. The headache is a direct consequence of the acute hypertensive crisis. This is a well-recognized and potentially dangerous adverse effect in Indian clinical practice, particularly in de-addiction programs where compliance may be poor. The key discriminator is that rebound hypertension is a *consequence of abrupt withdrawal*, not a direct pharmacological property of the drug itself. Gradual tapering of clonidine prevents this complication by allowing the sympathetic nervous system to readjust gradually. ## Why the other options are wrong **B. Receptor upregulation** — While receptor upregulation *does* occur during chronic clonidine therapy and is the *mechanism* underlying rebound hypertension, it is not itself the clinical condition causing the headache. Upregulation is a cellular adaptation process, not a pathological state. The question asks for the reason behind the *condition* (headache), which is the rebound hypertension that results from unopposed upregulated receptors—not the upregulation itself. **C. Receptor hypersensitivity** — Receptor hypersensitivity is a vague term and does not accurately describe the pharmacological mechanism. While upregulated receptors may be more responsive, the primary problem is not hypersensitivity but rather the *unopposed sympathetic surge* following withdrawal. This is a trap answer that confuses the mechanism with the clinical outcome. Hypersensitivity does not explain the acute hypertensive crisis. **D. Postural hypotension** — Postural hypotension (orthostatic hypotension) is actually a *side effect of clonidine therapy itself*, not a consequence of withdrawal. After abrupt discontinuation, blood pressure rises acutely due to rebound hypertension, not falls. This is a classic NBE trap: students may confuse the known side effect of clonidine (hypotension during therapy) with the withdrawal phenomenon (hypertension after stopping). ## High-Yield Facts - **Clonidine withdrawal syndrome** presents with rebound hypertension, headache, anxiety, and palpitations within 12–48 hours of abrupt discontinuation. - **α₂-agonist rebound hypertension** occurs because chronic drug use causes compensatory upregulation of α₂-receptors and increased sympathetic tone; withdrawal removes the suppression, causing unopposed catecholamine surge. - **Gradual tapering** (over 7–10 days) of clonidine prevents rebound hypertension by allowing sympathetic nervous system readjustment. - **Other α₂-agonists** (methyldopa, doxazosin) can also cause rebound hypertension if stopped abruptly; this is a class effect. - **Rebound hypertension is a clinical emergency** requiring reinitiation of the drug or use of alternative antihypertensives (β-blockers, vasodilators) to manage acute symptoms. ## Mnemonics **CLONIDINE WITHDRAWAL = REBOUND** **C**entral α₂-agonist → **L**ong-term use → **O**pposed sympathetic tone → **N**ow stopped → **I**ncreased catecholamines → **D**ramatic **H**ypertension → **I**ntense headache → **N**eed gradual **E** (exit/taper). Use when recalling clonidine withdrawal complications. **REBOUND = Receptor Upregulation + Unopposed** During chronic clonidine: receptors upregulate (body compensates). At withdrawal: upregulated receptors unopposed → sympathetic surge → hypertension. Memory hook: 'Upregulated + Unopposed = Rebound.' ## NBE Trap NBE pairs 'clonidine withdrawal' with 'receptor upregulation' to trap students who confuse the *mechanism* (upregulation) with the *clinical condition* (rebound hypertension). Students may also conflate clonidine's known side effect during therapy (postural hypotension) with its withdrawal effect (hypertension), leading to option D. ## Clinical Pearl In Indian de-addiction programs, clonidine is commonly used off-label for opioid and alcohol withdrawal. Abrupt discontinuation is a real risk in non-compliant patients or when supply is interrupted. Recognizing rebound hypertension as a medical emergency—and counseling patients on the need for gradual tapering—is critical to prevent stroke or myocardial infarction in this vulnerable population. _Reference: KD Tripathi Pharmacology Ch. 12 (Antihypertensives); Harrison Ch. 246 (Hypertension Management)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.